Article info
PDFLetter
Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H)
- Correspondence to: Dr Claire Hirst Helen Durham Neuro-inflammatory Centre, Department of Neurology, University Hospital of Wales, Heath Park, Cardiff CF14 4XN, UK; clairewarren_uk{at}yahoo.co.uk
Citation
Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H)
Publication history
- First published May 16, 2006.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 Journal of Neurology Neurosurgery and Psychiatry